Cristian Pereda
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Phase I trial of a heat-conditioned tumor lysate vaccine (TRIMELVax) in anti-PD-1 refractory melanoma: safety and immunological aspects (NCT06556004).
Journal: British journal of cancer
Published: November 03, 2025
Co-Expression of Immunohistochemical Markers MRP2, CXCR4, and PD-L1 in Gallbladder Tumors Is Associated with Prolonged Patient Survival.
Journal: Cancers
Published: June 06, 2023
Whole tumour cell-based vaccines: tuning the instruments to orchestrate an optimal antitumour immune response.
Journal: British journal of cancer
Published: April 04, 2023
Haptoglobin Induces a Specific Proteomic Profile and a Mature-Associated Phenotype on Primary Human Monocyte-Derived Dendritic Cells.
Journal: International journal of molecular sciences
Published: May 22, 2022
A heat-shocked melanoma cell lysate vaccine enhances tumor infiltration by prototypic effector T cells inhibiting tumor growth.
Journal: Journal for immunotherapy of cancer
Published: June 22, 2020
Dendritic Cells Loaded with Heat Shock-Conditioned Ovarian Epithelial Carcinoma Cell Lysates Elicit T Cell-Dependent Antitumor Immune Responses In Vitro.
Journal: Journal of immunology research
Published: March 25, 2019
IRE1α Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8+ T Cell Priming.
Journal: Frontiers in immunology
Published: May 20, 2018
Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: September 01, 2017
Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy.
Journal: Oncotarget
Published: July 28, 2017
Last Updated: 09/26/2026